June 23, 2018 11:10 AM ET


Company Overview of Kedem Pharmaceuticals, Inc.

Company Overview

Kedem Pharmaceuticals Inc., a development stage specialty pharmaceutical company, acquires and licenses healthcare related technologies for further development and re-licensing to pharmaceutical companies. The company develops a proprietary platform technology that delivers drugs through the sublingual route. Its products under development include X-Excite, a male sexual enhancement drug; Relax-B, an anti-stress drug; Nico-Z, a nicotine replacement product; V-Energy, an energy booster product; and T-Slim, an appetite suppressor drug. The company was formerly known as Global Health Ventures Inc. and changed its name to Kedem Pharmaceuticals Inc. in September 2011. Kedem Pharmaceuticals Inc. w...

8755 Ash Street

Suite 1

Vancouver, BC V6P 6T3


Founded in 2006

3 Employees



Key Executives for Kedem Pharmaceuticals, Inc.

Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary and Director
Age: 62
Chief Operating officer and Senior Vice President
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
10673242 Canada Inc. Americas
1113131 B.C. Ltd. Americas
1600978 Ontario Inc. Americas
2599708 Ontario Inc. Americas
4everPets Ltd. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kedem Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.